Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer. - Gombos A; Venet D; Ameye L; Vuylsteke P; Neven P; Richard V; Duhoux FP; Laes JF; Rothe F; Sotiriou C; Paesmans M; Awada A; et al. (NPJ breast cancer, 2022)